Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings
Press release: Cell & gene therapy accelerator to de-risk early stage research
Press release: improving the early detection, prevention and treatment of lung disease
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
